| |
| |
|
| Insider
Information: |
Smith Ian F |
| Relationship: |
|
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
267,823 |
|
|
Indirect Shares
|
5,306 |
|
|
| Direct
Value |
$22,116,413 |
|
|
|
Indirect Value
|
$2,416,034 |
|
|
| Total
Shares |
273,129 |
|
|
| Total
Value |
$24,532,447 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Vertex Pharmaceuticals Inc |
VRTX |
EVP, COO |
2018-06-29 |
46,699 |
2018-06-29 |
5,306 |
Premium* |
|
|
Acorda Therapeutics Inc |
ACOR |
Director |
2018-06-15 |
0 |
2016-01-04 |
0 |
Premium* |
|
|
Infinity Pharmaceuticals Inc |
INFI |
Director |
2018-06-12 |
45,845 |
2017-05-25 |
0 |
Premium* |
|
|
Solid Biosciences Inc |
SLDB |
|
2024-04-03 |
103,207 |
2020-12-10 |
0 |
Premium* |
|
|
Foghorn Therapeutics Inc. |
FHTX |
|
2021-04-27 |
72,072 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| VRTX |
Vertex Pharmaceuticals In... |
EVP & CFO |
• – – |
2013-04-19 |
4 |
OE |
$28.84 |
$25,545,249 |
D/D |
739,643 |
769,853 |
0 |
- |
|
| SLDB |
Solid Biosciences Inc |
Director |
– • – |
2022-12-02 |
4 |
A |
$0.00 |
$0 |
D/D |
13,172 |
356,380 |
0 |
- |
|
| SLDB |
Solid Biosciences Inc |
Director |
– • – |
2022-10-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
24,312 |
343,208 |
0 |
- |
|
| SLDB |
Solid Biosciences Inc |
Director |
– • – |
2022-07-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
24,313 |
318,896 |
0 |
- |
|
| SLDB |
Solid Biosciences Inc |
Director |
– • – |
2022-04-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
24,313 |
294,583 |
0 |
- |
|
| SLDB |
Solid Biosciences Inc |
Director |
– • – |
2020-12-10 |
4 |
A |
$3.70 |
$999,999 |
D/D |
270,270 |
270,270 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CFO & COO |
• – – |
2017-07-19 |
4 |
OE |
$77.31 |
$10,379,726 |
D/D |
123,400 |
249,638 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CFO & COO |
• – – |
2017-06-01 |
4 |
OE |
$37.86 |
$4,334,887 |
D/D |
98,553 |
224,791 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & CFO |
• – – |
2007-09-05 |
4 |
OE |
$26.20 |
$2,382,235 |
D/D |
90,925 |
171,039 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & CFO |
• – – |
2008-07-09 |
4 |
OE |
$9.07 |
$1,299,292 |
D/D |
81,436 |
165,737 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & CFO |
• – – |
2014-09-30 |
4 |
OE |
$33.28 |
$4,528,419 |
D/D |
107,624 |
152,894 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & CFO |
• – – |
2009-02-06 |
4 |
OE |
$10.41 |
$482,638 |
D/D |
41,212 |
134,747 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & CFO |
• – – |
2015-02-03 |
4 |
A |
$0.01 |
$207 |
D/D |
20,700 |
134,526 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CFO & COO |
• – – |
2017-02-03 |
4 |
A |
$0.00 |
$58 |
D/D |
20,923 |
133,922 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CFO & COO |
• – – |
2017-02-13 |
4 |
AS |
$87.66 |
$336,790 |
D/D |
(3,842) |
130,080 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CFO & COO |
• – – |
2017-05-15 |
4 |
AS |
$114.92 |
$33,786 |
D/D |
(294) |
126,238 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CFO & COO |
• – – |
2017-06-01 |
4 |
AS |
$124.00 |
$12,220,572 |
D/D |
(98,553) |
126,238 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CFO & COO |
• – – |
2017-07-19 |
4 |
AS |
$161.00 |
$19,867,400 |
D/D |
(123,400) |
126,238 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & CFO |
• – – |
2016-02-02 |
4 |
A |
$0.01 |
$173 |
D/D |
17,299 |
125,083 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & CFO |
• – – |
2015-02-18 |
4 |
AS |
$112.66 |
$1,168,428 |
D/D |
(10,350) |
124,176 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CFO & COO |
• – – |
2017-08-07 |
4 |
OE |
$77.31 |
$328,568 |
D/D |
4,250 |
120,138 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & CFO |
• – – |
2014-10-30 |
4 |
A |
$0.01 |
$750 |
D/D |
75,000 |
119,868 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & CFO |
• – – |
2015-03-23 |
4 |
AS |
$122.44 |
$759,277 |
D/D |
(6,042) |
118,134 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & CFO |
• – – |
2015-05-15 |
4 |
AS |
$123.85 |
$47,484 |
D/D |
(378) |
118,134 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CFO & COO |
• – – |
2017-08-02 |
4 |
OE |
$91.05 |
$196,213 |
D/D |
2,155 |
118,043 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
